AstraZeneca signs up to $555 million deal with US-based Algen to develop gene therapiesReuters • 10/06/25
Algen Biotechnologies Announces Multi-Target Partnership to Advance AI-Powered Drug Discovery in Immunology with AstraZenecaBusiness Wire • 10/06/25
Pharmaceutical Stocks: Valuations And Pipelines Are Only Beginning To Be AppreciatedSeeking Alpha • 10/03/25
AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?The Motley Fool • 10/02/25
AstraZeneca and other UK pharma boosted by Trump's first drug discount deal with PfizerProactive Investors • 10/01/25
AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditionsBusiness Wire • 09/26/25
Astrazeneca (AZN) Declines More Than Market: Some Information for InvestorsZacks Investment Research • 09/25/25